Status:
COMPLETED
Exploratory Study of Apple Watch Electrocardiographic Diagnostic Performance Enhanced by an Artificial Intelligence Algorithm
Lead Sponsor:
Cardiologs Technologies
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
22+ years
Brief Summary
This observational exploratory prospective study will evaluate the performance on an Artificial Intelligence (AI) solution interpreting ECG (electrocardiogram) collected from an Apple Watch (AI-AW) in...
Detailed Description
After being informed about the study, participants hospitalized for ablation or cardioversion or having a cardiac rhythm consultation at the investigational center will have Apple Watch ECG recordings...
Eligibility Criteria
Inclusion
- Patient aged 22 or older, able and willing to participate in the study
- Patient admitted to hospital for ablation, cardioversion or cardiac electrophysiological exploration or who come for regular rhythmology consultations
- Patient who has read the information note and has given his or her consent before any procedure related to the study
- Patient affiliated to social security
Exclusion
- Pregnant or breastfeeding women
- Patient with a pacemaker, implantable defibrillator or cardiac resynchronisation therapy device.
- Subject related to the investigator or any other staff member directly involved in the conduct of the study
- Patient incapable of giving consent, minor or adult patient protected by law
Key Trial Info
Start Date :
March 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 19 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04792905
Start Date
March 30 2021
End Date
July 19 2021
Last Update
September 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Cardiologique Paris Sud Hôpital Privé Jacques Cartier
Massy, France, 91300